ARTICLE | Regulation
Second-guessing
June 17, 1996 7:00 AM UTC
WASHINGTON - Based on phone calls to BioCentury last week, readers were wont to second-guess the deliberations of the Central and Nervous System Drugs Advisory Committee on Genentech Inc.'s Activase and Cephalon Inc.'s Myotrophin.
Their questions included: ...